Welcome to our dedicated page for SNUS news (Ticker: SNUS), a resource for investors and traders seeking the latest updates and insights on SNUS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SNUS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SNUS's position in the market.
Santander Holdings USA (SAN) will redeem all Series I preferred-related depositary shares on October 15, 2026 at $25 per Depositary Share.
The redemption covers 135,000 shares of Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series I and 5,400,000 NYSE: SNUS PF I depositary shares, each representing a 1/40th interest in a preferred share. The regular quarterly dividend has been declared and will be paid separately on October 15, 2026 to holders of record as of September 30, 2026. The book-entry Depositary Shares held through DTC will be redeemed under DTC procedures, with payment to DTC made by Broadridge Corporate Issuer Solutions as redemption agent.